American Surgical Association
ASA Main
Home
Meeting
Home
Preliminary
Program
Registration
Information
Hotel & Area
Information
Optional
Tour
Past & Future Meetings

Search Meeting

Back to 2017 Program


Health-Related Quality of Life and Functional Outcomes in 5-year Survivors After Pancreaticoduodenectomy
Zhi Ven Fong1, Donna M Alvino1, Carlos Fernández-del Castillo1, Ryan D Nipp1, Lara N Traeger1, Margaret Ruddy1, Carrie C Lubitz1, Colin D Johnson2, David C Chang1, Andrew L. Warshaw1, Keith D Lillemoe1, Cristina R Ferrone1
1Massachusetts General Hospital, Boston, MA; 2University of Southampton, Southampton, United Kingdom

OBJECTIVE(S): Long-term quality of life (QOL) after pancreaticoduodenectomy (PD) is unknown. Our aim was to assess QOL and functionality in a large cohort of patients ≥5-years after PD.
METHODS: The EORTC QLQ-C30 questionnaire was administered to patients who underwent PD between 1998 to 2011. Cohort’s scores were compared to an age- and gender-adjusted normal population. Clinical relevance (CR) of differences were scored as small (5-10), moderate (10-20), or large (>20) based on validated interpretation of clinically important differences.
RESULTS: Of 307 ≥5-year PD survivors, 243 (79.3%) responded, of whom 64.1% underwent PD for non-malignant lesions. Median follow-up was 9.1yrs (range 5.2yrs-15.4yrs). New-onset diabetes developed in 6.9%; 50.4% take pancrelipase; 54.6% take antacid medication. Compared to the age- and gender-adjusted controls, 5-year PD survivors demonstrated higher global QOL (78.7 vs 69.7, CR small, p<0.001), physical (86.7 vs 77.9, CR small, p<0.001) and role-functioning scores (86.3 vs 74.1, CR medium, p<0.001). On linear regression adjusting for socioeconomic variables, there were no differences in QOL or functional scores in the benign vs malignant subgroups. Age at operation was independently associated with physical-functioning (-0.4/year, p=0.008). Taking pancrelipase (-6.8, p=0.035) or antacids (-6.3, p=0.044) was independently associated with lower social-functioning scores.
CONCLUSIONS: Patients who had a PD demonstrated better global QOL, physical- and role-functioning scores at 5-years when compared to age- and gender-adjusted controls. Approximately half of patients required pancrelipase or antacids, while only 7% developed new-onset diabetes. Concerns over impaired QOL or functional status should not weigh negatively in the consideration for PD.


Back to 2017 Program


Philly Skyline Love Park Betsy Ross Tribute Love Statue